Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Malignant Melanoma

  Free Subscription


30.05.2016

1 Am J Dermatopathol
1 Ann Surg Oncol
4 Br J Dermatol
2 Cancer Res
1 Int J Cancer
2 J Am Acad Dermatol
1 J Biol Chem
1 J Clin Oncol
2 J Immunol
1 J Immunother
1 J Invest Dermatol
1 Lancet Oncol
3 Melanoma Res
1 Oncogene
2 Oncol Rep
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Dermatopathol

  1. ANTONOV NK, Niedt GW
    Malignant Melanoma With Rhabdomyosarcomatous Differentiation: A Case Report.
    Am J Dermatopathol. 2016;38:456-460.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. SONDAK VK, Messina JL
    Prediction is Difficult, Especially About the Future: Clinical Prognostic Tools in Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


    Br J Dermatol

  3. TRAUTMANN F, Meier F, Seidler A, Schmitt J, et al
    Effects of the German skin cancer screening program on melanoma incidence and indicators of disease severity.
    Br J Dermatol. 2016 May 20. doi: 10.1111/bjd.14758.
    PubMed     Text format     Abstract available

  4. RANSOHOFF KJ, Stefanick ML, Li S, Kurian AW, et al
    Association of non-melanoma skin cancer with second non-cutaneous malignancy in the Women's Health Initiative.
    Br J Dermatol. 2016 May 26. doi: 10.1111/bjd.14766.
    PubMed     Text format     Abstract available

  5. PIANA S, Moscarella E, Longo C
    Image Gallery: Brain? no, melanoma.
    Br J Dermatol. 2016;174:e41.
    PubMed     Text format    

  6. SCHOFIELD JK, Robinson R, Reeken S, Jackson R, et al
    National Institute for Health and Care Excellence melanoma guidelines: good news for patients but challenging to implement.
    Br J Dermatol. 2016;174:949-50.
    PubMed     Text format    


    Cancer Res

  7. HARBST K, Lauss M, Cirenajwis H, Isaksson K, et al
    Multi-region whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma.
    Cancer Res. 2016 May 23. pii: canres.3476.2016.
    PubMed     Text format     Abstract available

  8. LAZAR I, Clement E, Dauvillier S, Milhas D, et al
    Adipocyte exosomes promote melanoma aggressiveness through fatty acid oxidation: a novel mechanism linking obesity and cancer.
    Cancer Res. 2016 May 23. pii: canres.0651.2016.
    PubMed     Text format     Abstract available


    Int J Cancer

  9. ORTEGA-MARTINEZ I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, et al
    Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early stage melanoma.
    Int J Cancer. 2016 May 23. doi: 10.1002/ijc.30202.
    PubMed     Text format     Abstract available


    J Am Acad Dermatol

  10. DIKA E, Patrizi A, Fanti PA, Christman H, et al
    An asymptomatic subungual nodule.
    J Am Acad Dermatol. 2016;74:e27-8.
    PubMed     Text format    

  11. CARNEY PA, Frederick PD, Reisch LM, Knezevich S, et al
    How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.
    J Am Acad Dermatol. 2016;74:317-24.
    PubMed     Text format     Abstract available


    J Biol Chem

  12. ZHOU B, Ritt DA, Morrison DK, Der CJ, et al
    CK2alpha Maintains ERK Activity in a Kinase-independent Manner to Promote Resistance to Inhibitors of RAF and MEK but not ERK in BRAF-mutant Melanoma.
    J Biol Chem. 2016 May 17. pii: jbc.M115.712885.
    PubMed     Text format     Abstract available


    J Clin Oncol

  13. GOFF SL, Dudley ME, Citrin DE, Somerville RP, et al
    Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma.
    J Clin Oncol. 2016 May 23. pii: JCO667220.
    PubMed     Text format     Abstract available


    J Immunol

  14. ISH-SHALOM E, Meirow Y, Sade-Feldman M, Kanterman J, et al
    Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications.
    J Immunol. 2016;196:156-67.
    PubMed     Text format     Abstract available

  15. TSURUTANI N, Mittal P, St Rose MC, Ngoi SM, et al
    Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis.
    J Immunol. 2016;196:124-34.
    PubMed     Text format     Abstract available


    J Immunother

  16. BOUDEWIJNS S, Westdorp H, Koornstra RH, Aarntzen EH, et al
    Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.
    J Immunother. 2016.
    PubMed     Text format     Abstract available


    J Invest Dermatol

  17. YELAMOS O, Merkel EA, Sholl LM, Zhang B, et al
    Non-overlapping Clinical and Mutational Patterns in Melanomas from the Female Genital Tract and Atypical Genital Nevi.
    J Invest Dermatol. 2016 May 21. pii: S0022-202X(16)31256.
    PubMed     Text format     Abstract available


    Lancet Oncol

  18. TANDAY S
    Severe sleep apnoea linked to melanoma risk.
    Lancet Oncol. 2016 May 19. pii: S1470-2045(16)30161.
    PubMed     Text format    


    Melanoma Res

  19. VAN DER PLOEG IM, Madu MF, van der Hage JA, Wouters MW, et al
    Blue dye can be safely omitted in most sentinel node procedures for melanoma.
    Melanoma Res. 2016.
    PubMed     Text format     Abstract available

  20. KUK SK, Won CH, Lee WJ, Shin WJ, et al
    Prognostic significance of nestin in primary malignant melanoma of the oral cavity.
    Melanoma Res. 2016.
    PubMed     Text format     Abstract available

  21. HUGEL R, Muendlein A, Volbeding L, Drexel H, et al
    Serum levels of hepatocyte growth factor as a potential tumor marker in patients with malignant melanoma.
    Melanoma Res. 2016.
    PubMed     Text format     Abstract available


    Oncogene

  22. DE DONATIS GM, Le Pape E, Pierron A, Cheli Y, et al
    NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2.
    Oncogene. 2016;35:2813.
    PubMed     Text format    


    Oncol Rep

  23. CHEN Y, Zhang Z, Luo C, Chen Z, et al
    MicroRNA-18b inhibits the growth of malignant melanoma via inhibition of HIF-1alpha-mediated glycolysis.
    Oncol Rep. 2016 May 20. doi: 10.3892/or.2016.4824.
    PubMed     Text format     Abstract available

  24. SIM DY, Sohng JK, Jung HJ
    Anticancer activity of 7,8-dihydroxyflavone in melanoma cells via downregulation of alpha-MSH/cAMP/MITF pathway.
    Oncol Rep. 2016 May 20. doi: 10.3892/or.2016.4825.
    PubMed     Text format     Abstract available


    PLoS One

  25. KESKINOV AA, Tapias V, Watkins SC, Ma Y, et al
    Impact of the Sensory Neurons on Melanoma Growth In Vivo.
    PLoS One. 2016;11:e0156095.
    PubMed     Text format     Abstract available

  26. GUGGER A, Barnhill RL, Seifert B, Dehler S, et al
    Cutaneous Melanoma with Brain Metastasis: Report of 193 Patients with New Observations.
    PLoS One. 2016;11:e0156115.
    PubMed     Text format     Abstract available

  27. BEIDERWELLEN K, Geraldo L, Ruhlmann V, Heusch P, et al
    Accuracy of [18F]FDG PET/MRI for the Detection of Liver Metastases.
    PLoS One. 2015;10:e0137285.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Pfizer Oncology.

Design: